Source: International Congress 2016 – How the increasing complexity of chronic care management challenges ethics and costs in our healthcare system
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Jonathan Corren (Los Angeles, United States of America), Jonathan Corren, Pascal Chanez, Mario Castro, Leonardo Fabbri, Vijay N. Joish, Robert E. Evans, Neil M.H. Graham, Vera Mastey, Sara Villeneuve, Gaëlle Bégo-Le Bagousse, Christine Taniou, Puneet Mahajan, Ariel Teper, Gianluca Pirozzi, Laurent Eckert. Dupilumab reduces severe exacerbation-related costs among asthma patients: Results from a phase 2b trial. Eur Respir J 2016; 48: Suppl. 60, 1530

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Benralizumab reduces exacerbations in severe, uncontrolled asthma: Results of the phase III CALIMA trial Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 Influence of patient baseline characteristics and concomitant medication on outcomes in long-term trials of COPD: Analysis of the UPLIFT® trial Source: Annual Congress 2013 –Clinical trials of LAMAs, LABAs, MABAs and theophylline for asthma and COPD Year: 2013 Dupilumab improves patient-reported outcomes in chronic sinusitis with nasal polyps patients with comorbid asthma: Results from a phase 2a trial Source: International Congress 2016 – Best abstracts in asthma and COPD Year: 2016 Randomised crossover trial of telemonitoring in chronic respiratory patients (TeleCRAFT trial*): No impact on hospital admissions and quality of life (QOL) Source: International Congress 2014 – Best abstracts in chronic care Year: 2014 A self-treatment programme in patients with COPD: Effectiveness for the reduction of severe exacerbations Source: International Congress 2015 – Latest insights into chronic care Year: 2015 Effect of exacerbation history and ICS use on outcomes in COPD patients from the TIOSPIR™ trial Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 Respiratory effectiveness group study: Predictors of frequent severe asthma exacerbations Source: International Congress 2015 – Management of asthma and COPD in primary care Year: 2015 Effects of case management on hospitalisation and exacerbation rate in severe, complex COPD: A randomized controlled trial Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Comprehensive care programme for patients with chronic obstructive pulmonary disease (COPD) --- A randomized controlled trial (RCT) Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Analysis of the frequency of COPD exacerbations in the ’real-life’ DACCORD study over a 2 year period Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 4–year trajectory of medication adherence amongst severe asthma patients: Risk factors and impact on asthma control Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma Year: 2016 Late Breaking Abstract - Can a self-management plan, which includes a four-fold increase in inhaled corticosteroid dose, reduce severe asthma exacerbations: a randomised, pragmatic trial. Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017 Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016 Predictors of effectiveness of omalizumab treatment in patients with severe asthma recruited in a real-life setting Source: International Congress 2015 – New data on established treatments for asthma and COPD Year: 2015 The parameters that may affect inhalation therapy success in elderly COPD and asthma patients Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Effect of telehealthcare on exacerbations and hospital admissions in COPD: A randomised controlled trial Source: International Congress 2015 – Best abstracts in pulmonary rehabilitation and chronic care Year: 2015 Characteristics and medication use of the patients with acute exacerbations of asthma-COPD overlap syndrome Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage? Year: 2015 Patients’ adherence to chronic treatment in lung diseases: Preliminary data from a randomized controlled trial Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016